Chin Med. 2026 May 29;21(1):154. doi: 10.1186/s13020-026-01400-5.ABSTRACTBACKGROUND: Hypertrophic cardiomyopathy (HCM) is often complicated by coronary microvascular dysfunction (CMD), which precipitates localized myocardial ischemia and metabolic disturbance, triggering compensatory cardiomyocyte h
Biomark Res. 2026 May 29. doi: 10.1186/s40364-026-00947-7. Online ahead of print.ABSTRACTCardiac troponin is essential for diagnosing myocardial infarction, yet high-sensitivity assays frequently detect troponin elevations in non-ischemic contexts, complicating clinical decision-making. We investiga
BMC Cardiovasc Disord. 2026 May 30. doi: 10.1186/s12872-026-05910-w. Online ahead of print.ABSTRACTOBJECTIVE: This study explored the incidence and risk factors of acute kidney injury (AKI) in patients with hypertrophic obstructive cardiomyopathy (HOCM) undergoing modified Morrow septal myectomy and
JACC Case Rep. 2026 May 29:108559. doi: 10.1016/j.jaccas.2026.108559. Online ahead of print.ABSTRACTBACKGROUND: Hypertrophic cardiomyopathy (HCM) affects approximately 20% of patients with Noonan syndrome and contributes significantly to mortality, particularly in neonates with severe HCM and left v
Eur Heart J Case Rep. 2026 May 16;10(5):ytag363. doi: 10.1093/ehjcr/ytag363. eCollection 2026 May.ABSTRACTBACKGROUND: Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiomyopathy and is frequently complicated by left ventricular outflow tract (LVOT) obstruction. While most cases are
Cureus. 2026 Apr 27;18(4):e107801. doi: 10.7759/cureus.107801. eCollection 2026 Apr.ABSTRACTIn clinical practice, apical hypertrophic cardiomyopathy (HCM) is an insidious phenotype that often conceals significant structural complications. Our case demonstrates a critical "clinical pearl": the necess
Front Cardiovasc Med. 2026 May 13;13:1818565. doi: 10.3389/fcvm.2026.1818565. eCollection 2026.ABSTRACTBACKGROUND: Eosinophilic myocarditis (EM) is a rare and potentially life-threatening inflammatory heart disease. Diagnosis is frequently delayed because clinical presentations are heterogeneous, ea
JRSM Cardiovasc Dis. 2026 May 26;15:20480040261431384. doi: 10.1177/20480040261431384. eCollection 2026 Jan-Dec.ABSTRACTHypertrophic cardiomyopathy (HCM) stands as the most common monogenic cardiac disease, with an estimated prevalence historically reported as 1:500, but likely closer to 1:200 based
No abstractJ Cardiovasc Imaging. 2026 May 28;34(1):12. doi: 10.1186/s44348-026-00067-8.NO ABSTRACTPMID:42210443 | DOI:10.1186/s44348-026-00067-8
Heart. 2026 May 28:heartjnl-2025-327169. doi: 10.1136/heartjnl-2025-327169. Online ahead of print.ABSTRACTBACKGROUND: The impact of COVID-19 in hypertrophic cardiomyopathy (HCM), particularly in the post-vaccine era, remains incompletely understood. We evaluated whether pre-existing cardiovascular m
Int J Cardiol. 2026 May 27:134582. doi: 10.1016/j.ijcard.2026.134582. Online ahead of print.ABSTRACTBACKGROUND: Sex-related differences in cardiomyopathy (CMP) may influence clinical presentation, diagnostic evaluation, access to advanced therapies and outcomes. Despite this, women remain substantia
No abstractArch Cardiol Mex. 2026 May 28. doi: 10.24875/ACM.25000303. Online ahead of print.NO ABSTRACTPMID:42208467 | DOI:10.24875/ACM.25000303
No abstractJ Invasive Cardiol. 2026 May 27. doi: 10.25270/jic/26.00152. Online ahead of print.NO ABSTRACTPMID:42207831 | DOI:10.25270/jic/26.00152
No abstractJACC Adv. 2026 May;5(5):102735. doi: 10.1016/j.jacadv.2026.102735.NO ABSTRACTPMID:42206791 | DOI:10.1016/j.jacadv.2026.102735
JACC Case Rep. 2026 May 27;31(21):108369. doi: 10.1016/j.jaccas.2026.108369.ABSTRACTThis article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief an
Exp Biol Med (Maywood). 2026 May 12;251:10945. doi: 10.3389/ebm.2026.10945. eCollection 2026.ABSTRACTCardiovascular diseases represent the leading cause of global mortality and disability, posing a severe threat to human health. Accumulating evidence suggests that antigen-antibody-mediated immune re
Acta Cardiol Sin. 2026 May;42(3):296-338. doi: 10.6515/ACS.202605_42(3).20260410A.ABSTRACTHypertrophic cardiomyopathy (HCM) is the most common genetic heart disease worldwide. However, only a small percentage of cases are diagnosed clinically, suggesting under-recognition, with most clinicians expos
No abstractActa Cardiol Sin. 2026 May;42(3):293-295. doi: 10.6515/ACS.202605_42(3).20260420A.NO ABSTRACTPMID:42205121 | PMC:PMC13202353 | DOI:10.6515/ACS.202605_42(3).20260420A
Korean Circ J. 2026 May 12. doi: 10.4070/kcj.2026.0049. Online ahead of print.ABSTRACTBACKGROUND AND OBJECTIVES: Prognosis and risk markers of sudden cardiac death (SCD) remain incompletely defined in patients with apical hypertrophic cardiomyopathy (HCM). This study evaluated established SCD risk m
Biol Pharm Bull. 2026;49(5):872-887. doi: 10.1248/bpb.b26-00025.ABSTRACTMutations in the MYH7 gene, which encodes β-myosin heavy chain (β-MHC), are a significant cause of hypertrophic cardiomyopathy (HCM). These variants may lead to variable clinical outcomes, thereby influencing responsiveness to t
JACC Adv. 2026 Apr 28;5(5):102767. doi: 10.1016/j.jacadv.2026.102767. Online ahead of print.ABSTRACTBACKGROUND: There are limited data on the impact of frailty in patients undergoing alcohol septal ablation (ASA) for the treatment of hypertrophic obstructive cardiomyopathy (HOCM).OBJECTIVES: The obj
Front Physiol. 2026 May 11;17:1740128. doi: 10.3389/fphys.2026.1740128. eCollection 2026.ABSTRACTINTRODUCTION: Cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year. Most heart cardiomyopathies result in an increased need for protein
Diagnostics (Basel). 2026 May 20;16(10):1558. doi: 10.3390/diagnostics16101558.ABSTRACTBackground/Objectives: Differentiating clinically suspected cardiac amyloidosis from hypertrophic cardiomyopathy (HCM) remains a significant clinical challenge, especially when contrast-enhanced imaging is contrai
Life (Basel). 2026 Apr 29;16(5):738. doi: 10.3390/life16050738.ABSTRACT(1) Background: The characteristics of rare diseases (RDs) vary considerably-not only between different disease types but also between individual patients with the same condition. In the Roma community, we analyzed the most frequ
